Related Experiment Video
Updated: Mar 7, 2026
04:25
Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
Published on: November 8, 2024
2.4K
Delayed Cutaneous Hypersensitivity Responses in Patients with Warts
Indian Journal of Dermatology, Venereology and Leprology
|February 21, 2017
Summary
Patients with viral warts showed weakened immune responses to various antigens, including recall antigens, DNCB, and croton oil, compared to healthy individuals. This suggests an impaired cellular immunity in individuals suffering from warts.
Area of Science:
- Immunology
- Dermatology
- Virology
Background:
- Viral warts are benign skin growths caused by human papillomaviruses.
- Cellular immunity plays a crucial role in controlling viral infections, including those causing warts.
Purpose of the Study:
- To investigate the immune status of patients with viral warts.
- To compare the immune responses to various antigens in patients with warts versus controls.
Main Methods:
- Twenty-five patients with viral warts were tested.
- Immune responses were evaluated using secondary (recall) antigens, primary delayed (DNCB), and inflammatory (croton oil) antigens.
Main Results:
- Patients with viral warts exhibited significantly depressed immune responses to the tested antigens.
- A notable difference in immune reactivity was observed when comparing wart patients to control groups.
Conclusions:
- Viral wart patients demonstrate impaired cellular immune function.
- These findings highlight a potential link between weakened immunity and the development or persistence of viral warts.
More Related Videos
Related Concept Videos
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
102
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
102
01:30Hypersensitivities
8.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.0K
01:30Drug Toxicity: Allergic Reactions
80
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80
01:01Hypersensitivity Reactions: Cytolytic Reactions
81
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
81
01:19Hypersensitivity Reactions: Immune-Complex Reactions
73
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
73
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
265
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
265